The regulation of tyrosine phosphorylation and associated signalling through antigen, growth-factor and cytokine receptors is mediated by the reciprocal activities of protein tyrosine kinases and protein tyrosine phosphatases (PTPases)1. The transmembrane PTPase CD45 is a key regulator of antigen receptor signalling in T and B cells2,3. Src-family kinases have been identified as primary molecular targets for CD45 (ref. 4). However, CD45 is highly expressed in all haematopoietic lineages at all stages of development5, indicating that CD45 could regulate other cell types and might act on additional substrates. Here we show that CD45 suppresses JAK (Janus kinase) kinases and negatively regulates cytokine receptor signalling. Targeted disruption of the cd45 gene leads to enhanced cytokine and interferon-receptor-mediated activation of JAKs and STAT (signal transducer and activators of transcription) proteins. In vitro , CD45 directly dephosphorylates and binds to JAKs. Functionally, CD45 negatively regulates interleukin-3-mediated cellular proliferation, erythropoietin-dependent haematopoieisis and antiviral responses in vitro and in vivo. Our data identify an unexpected and novel function for CD45 as a haematopoietic JAK phosphatase that negatively regulates cytokine receptor signalling.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Tonks, N. K. & Neel, B. G. From form to function: signaling by protein tyrosine phosphatases. Cell 87, 365–368 (1996).
Kishihara, K. et al. Normal B lymphocyte development but impaired T cell maturation in CD45- exon6 protein tyrosine phosphatase-deficient mice. Cell 74, 143–156 (1993).
Byth, K. F. et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J. Exp. Med. 183, 1707–1718 (1996).
Trowbridge, I. S. & Thomas, M. L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12, 85–116 (1994).
Thomas, M. L. The leukocyte common antigen family. Annu. Rev. Immunol. 7, 339–369 (1989).
de Groot, R. P., Coffer, P. J. & Koenderman, L. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal. 10, 619–628 (1998).
Leonard, W. J. & O'Shea, J. J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16, 293– 322 (1998).
Matsumura, I. et al. Transcriptional regulation of the cyclin D1 promoter by STAT5: its involvement in cytokine-dependent growth of hematopoietic cells. EMBO J. 18, 1367–1377 ( 1999).
Hanke, J. H. et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271, 695–701 (1996).
Felberg, J. & Johnson, P. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions. J. Biol. Chem. 273, 17839– 17845 (1998).
McKenney, D. W., Onodera, H., Gorman, L., Mimura, T. & Rothstein, D. M. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J. Biol. Chem. 270, 24949–24954 (1995).
Ihle, J. N. Cytokine receptor signalling. Nature 377, 591–594 (1995).
Petricoin, E. F. I. et al. Antiproliferative action of interferon-α requires components of T-cell-receptor signalling. Nature 390, 629–632 (1997).
Parganas, E. et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385– 395 (1998).
Marine, J. C. et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 98, 617–627 (1999).
Rodig, S. J. et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373–383 ( 1998).
Kandolf, R., Canu, A. & Hofschneider, P. H. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol. 17, 167–181 ( 1985).
Ward, A. C., Touw, I. & Yoshimura, A. The Jak–Stat pathway in normal and perturbed hematopoiesis. Blood 95, 19–29 (2000).
Yasukawa, H. et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309–1320 (1999).
Klingmüller, U., Lorenz, U., Cantley, L. C., Neel, B. G. & Lodish, H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80, 729– 738 (1995).
Ratei, R. et al. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Ann. Hematol. 77, 107–114 ( 1998).
Ozdemirli, M., Mankin, H. J., Aiesenberg, A. C. & Harris, N. L. Hodgkin's disease presenting as a solitary bone tumor. A report of four cases and review of the literature. Cancer 77, 79–88 (1996).
Kung, C. et al. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nature Medicine 6, 343–345 (2000).
Saad, M. J., Carvalho, C. R., Thirone, A. C. & Velloso, L. A. Insulin induces tyrosine phosphorylation of JAK2 in insulin-sensitive tissues of the intact rat. J. Biol. Chem. 271, 22100 –22104 (1996).
Ren, J. M. et al. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. Diabetes 47, 493–497 (1998).
Liu, Q. et al. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13, 786–791 (1999).
Chaturvedi, P., Sharma, S. & Reddy, E. P. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17, 3295– 3304 (1997).
We thank M. Saunders for scientific editing; T. Mak for providing CD45 mutant mice; and T. Mak, M. Reth, W. Yeh, D. Barber, V. Stambolic, C. Mirtsos, K. Bachmaier, A. Oliveira-dos-Santos, M. Crackower, Y. Kong, N. Joza, I. Kozieradzki and Q. Liu for comments and advice. This work was supported by grants from the Canadian Institutes for Health Research (CIHR) and the National Cancer Institute (NCI) of Canada and Amgen to J.M.P., and from the NIH to D.M.R. J.M.P. holds a Canadian Research Chair in Cell Biology.
About this article
Cite this article
Irie-Sasaki, J., Sasaki, T., Matsumoto, W. et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409, 349–354 (2001). https://doi.org/10.1038/35053086
Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy
Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species
Journal of Neurochemistry (2021)
Clinical features and outcome of pediatric acute lymphoblastic leukemia with low peripheral blood blast cell count at diagnosis
Blood Cells, Molecules, and Diseases (2021)
Intracellular immune sensing promotes inflammation via gasdermin D–driven release of a lectin alarmin
Nature Immunology (2021)